IL72034A - Oral pharmaceutical compositions containing difficultly soluble antidiabetic agents and their preparation - Google Patents

Oral pharmaceutical compositions containing difficultly soluble antidiabetic agents and their preparation

Info

Publication number
IL72034A
IL72034A IL72034A IL7203484A IL72034A IL 72034 A IL72034 A IL 72034A IL 72034 A IL72034 A IL 72034A IL 7203484 A IL7203484 A IL 7203484A IL 72034 A IL72034 A IL 72034A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
preparation
compositions
active substance
Prior art date
Application number
IL72034A
Other languages
English (en)
Other versions
IL72034A0 (en
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of IL72034A0 publication Critical patent/IL72034A0/xx
Publication of IL72034A publication Critical patent/IL72034A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
IL72034A 1983-06-08 1984-06-05 Oral pharmaceutical compositions containing difficultly soluble antidiabetic agents and their preparation IL72034A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833320582 DE3320582A1 (de) 1983-06-08 1983-06-08 Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
IL72034A0 IL72034A0 (en) 1984-10-31
IL72034A true IL72034A (en) 1987-09-16

Family

ID=6200885

Family Applications (1)

Application Number Title Priority Date Filing Date
IL72034A IL72034A (en) 1983-06-08 1984-06-05 Oral pharmaceutical compositions containing difficultly soluble antidiabetic agents and their preparation

Country Status (25)

Country Link
US (2) US4696815A (fi)
EP (1) EP0128483B1 (fi)
JP (1) JPS6069038A (fi)
KR (1) KR910004571B1 (fi)
AT (1) ATE56365T1 (fi)
AU (1) AU563642B2 (fi)
CA (1) CA1228299A (fi)
DD (1) DD224216A5 (fi)
DE (2) DE3320582A1 (fi)
DK (1) DK162019C (fi)
ES (1) ES8506446A1 (fi)
FI (1) FI85217C (fi)
GB (1) GB2142236B (fi)
GR (1) GR82362B (fi)
HK (1) HK72387A (fi)
HU (1) HU193932B (fi)
IE (1) IE57793B1 (fi)
IL (1) IL72034A (fi)
MY (1) MY100795A (fi)
NO (1) NO168628C (fi)
NZ (1) NZ208417A (fi)
PH (1) PH24567A (fi)
PT (1) PT78710B (fi)
SG (1) SG48187G (fi)
ZA (1) ZA844296B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3320582A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung
DE3320583A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
US5312924A (en) 1983-12-30 1994-05-17 Dr. Karl Thomae Gmbh Phenylacetic acid benzylamides
US4819238A (en) * 1987-10-26 1989-04-04 Hughes Aircraft Company Wide band free electron laser with variable phase and frequency
US5258185A (en) * 1989-08-23 1993-11-02 Bauer Kurt H Highly active, rapidly absorbable formulations of glibenclamide, processes for the production thereof and their use
US5024843A (en) * 1989-09-05 1991-06-18 Alza Corporation Oral hypoglycemic glipizide granulation
CH678920A5 (fi) * 1989-11-14 1991-11-29 Gergely Gerhard
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
WO1998001117A1 (en) 1996-07-08 1998-01-15 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
WO1999004818A1 (fr) * 1997-07-24 1999-02-04 Eisai Co., Ltd. Composition pour preparation pharmaceutique et son procede de production
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6099862A (en) 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
IL143375A0 (en) * 1999-09-30 2002-04-21 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
US6703045B2 (en) 2001-08-21 2004-03-09 Council Of Scientific & Industrial Research Composition and method for maintaining blood glucose level
WO2003026637A2 (en) * 2001-09-28 2003-04-03 Sun Pharmaceutical Industries Limited Dosage form for treatment of diabetes mellitus
AU2002350719A1 (en) * 2002-11-29 2004-06-23 Janssen Pharmaceutica N.V. Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
WO2005023789A1 (en) * 2003-09-10 2005-03-17 Biocon Limited Phosphoric acid salt of (s)-(+)-2-ethoxy-4-{[3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid
AU2003269481A1 (en) * 2003-09-10 2005-03-29 Biocon Limited (s)-(+)-2-ethoxy-4-{(3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl)-methyl}-benzoic acid sodium salt
TR200704897A1 (tr) 2007-07-13 2009-02-23 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Uzatılmış salım sağlayan gliklazid formülasyonları@
EP2181705A1 (en) 2008-10-31 2010-05-05 Disphar International B.V. Sustained-release formulation of gliclazide
EP2468268B1 (en) 2010-12-21 2017-12-13 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Combination composition of vildagliptin and gliclazide
TR201107482A1 (tr) 2010-12-21 2012-07-23 Sanovel İlaç San.Ve Ti̇c.A.Ş. Vildagliptin ve gliklazidin iki tabakalı kombinasyon kompozisyonu.
TR201103946A1 (tr) 2011-04-22 2012-11-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Kontrollü salım sağlayan gliklazid formülasyonları.
EP2779999A2 (en) 2011-11-15 2014-09-24 Dr. Reddy's Laboratories Ltd. Pharmaceutical formulations comprising atorvastatin and glimepiride
WO2014128116A1 (en) 2013-02-19 2014-08-28 Sanovel Ilac Sanayi Ve Ticaret A.S. A production process for gliclazide formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1187259A (en) * 1967-10-23 1970-04-08 Hexachimie New Aminoalkyl Esters of 2-Anilino-Nicotinic Acids and process for their manufacture
US3668215A (en) * 1967-11-25 1972-06-06 Bayer Ag Aryl-sulphonyl-semicarbazides containing heterocyclic acylamino groups
NL138933B (nl) * 1969-03-26 1973-05-15 Erba Carlo Spa Werkwijze voor het bereiden van benzeensulfonylureumderivaten met bloedsuikerspiegelverlagende werking.
NL7314765A (fi) * 1972-10-31 1974-05-02
DE2657382A1 (de) * 1976-12-17 1978-06-29 Thera Ges Fuer Patente Orales antidiabetikmittel
DE3175410D1 (en) * 1980-07-29 1986-11-06 Sanofi Sa Acid stabilized compositions of thieno-pyridine derived compounds and process for preventing degradation of such compounds
US4430399A (en) * 1980-09-25 1984-02-07 Duracell Inc. Method of electrode formation and article
DE3100535A1 (de) * 1981-01-10 1982-08-12 Dr. Karl Thomae Gmbh, 7950 Biberach "neue carbonsaeure-derivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3225188A1 (de) * 1982-07-06 1984-01-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue phenylessigsaeurederivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
DE3126703A1 (de) * 1981-07-07 1983-01-27 Dr. Karl Thomae Gmbh, 7950 Biberach Bromhexin-retardform und verfahren zu ihrer herstellung
GB2118040A (en) * 1982-02-15 1983-10-26 Hoechst Uk Ltd Oral anti-diabetic preparation
DE3320582A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
CA1228299A (en) 1987-10-20
DK162019C (da) 1992-02-10
AU2924084A (en) 1984-12-13
US4863724A (en) 1989-09-05
ES533208A0 (es) 1985-08-01
EP0128483A2 (de) 1984-12-19
FI85217C (fi) 1992-03-25
KR910004571B1 (ko) 1991-07-06
HK72387A (en) 1987-10-16
IE841423L (en) 1984-12-08
IL72034A0 (en) 1984-10-31
PT78710B (de) 1986-10-21
ATE56365T1 (de) 1990-09-15
DK281184A (da) 1984-12-09
ES8506446A1 (es) 1985-08-01
EP0128483A3 (en) 1986-07-02
PH24567A (en) 1990-08-03
NO168628C (no) 1992-03-18
FI85217B (fi) 1991-12-13
MY100795A (en) 1991-02-28
HU193932B (en) 1987-12-28
DK281184D0 (da) 1984-06-07
PT78710A (de) 1984-07-01
DD224216A5 (de) 1985-07-03
SG48187G (en) 1988-01-15
ZA844296B (en) 1986-02-26
HUT34689A (en) 1985-04-28
AU563642B2 (en) 1987-07-16
FI842294A (fi) 1984-12-09
DE3320582A1 (de) 1984-12-13
GB2142236A (en) 1985-01-16
KR850000240A (ko) 1985-02-26
GR82362B (fi) 1984-12-13
GB2142236B (en) 1987-04-08
GB8414529D0 (en) 1984-07-11
IE57793B1 (en) 1993-04-07
NO842290L (no) 1984-12-10
JPH0587492B2 (fi) 1993-12-16
DK162019B (da) 1991-09-09
FI842294A0 (fi) 1984-06-07
JPS6069038A (ja) 1985-04-19
DE3483175D1 (de) 1990-10-18
NO168628B (no) 1991-12-09
EP0128483B1 (de) 1990-09-12
US4696815A (en) 1987-09-29
NZ208417A (en) 1987-07-31

Similar Documents

Publication Publication Date Title
IL72034A (en) Oral pharmaceutical compositions containing difficultly soluble antidiabetic agents and their preparation
IL72033A (en) Oral pharmaceutical compositions containing difficultly soluble antidiabetic agents and their preparation

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed